OssDsign signs contract with 100 VA orthopedic hospitals
"OssDsign secures contract with U.S. Department of Veterans Affairs to provide orthobiologic products to 100 additional VA hospitals nationwide, expanding acces
Stay updated with breaking news from Ossdsign Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"OssDsign secures contract with U.S. Department of Veterans Affairs to provide orthobiologic products to 100 additional VA hospitals nationwide, expanding acces
STOCKHOLM – 26 April 2024. Karolinska Development AB today publishes its Interim Report - January-March 2024. The full report is available on the Company's website. “2024 has begun strongly with...
STOCKHOLM – 16 February 2024. Karolinska Development AB today publishes its Year-end Report - January-December 2023. The full report is available on the Company's website. “2023 has been a year...
Uppsala, January 24, 2024. OssDsign AB (publ.) today announces that the previously communicated outstanding 12-month results from the clinical study TOP FUSION have been published in the peer-reviewed journal Biomedical Journal of Scientific & Technical Research. The results show a 93 % spinal fusion rate as well as improvements in quality of life and pain following surgery with the novel nanosynthetic bone graft OssDsign Catalyst.
Uppsala, January 9, 2024. OssDsign AB today announces that positive data from the clinical study TOP FUSION has been submitted to a peer-reviewed scientific journal. Top-line results show a 93 %...